Thomas Flautt is a Cardiology physician affiliated with Houston Methodist. OpenAlex indexes 49 publications with 1,201 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6550 Fannin St Ste 1801
Houston, TX 770302744
Telephone
713-441-1100Provider last certified this registry record 18 Aug 2021.
Industry payments
42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Biosense Webster, Inc.Program year202543 payments$15,360openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year202525 payments
- Abbott LaboratoriesProgram year202520 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
66.4%Beta blocker20.7%Metoprolol Succinate53%Sotalol26%Carvedilol9%Bisoprolol Fumarate7%Metoprolol Tartrate3%Propranolol Hcl Er2%Part D<11 patientsAntiarrhythmic19.2%Flecainide Acetate59%Amiodarone Hcl39%Propafenone Hcl3%Part D<11 patients+ 12 more classes in this area
Blood & clotting
14.5%Factor Xa inhibitor12.7%Eliquis82%Xarelto18%Part D≥57 patientsP2Y12 inhibitor1.8%Clopidogrel100%Part D≥16 patientsMetabolism & gastrointestinal
12.7%SGLT2 inhibitor4.3%Jardiance61%Farxiga39%Part D<11 patientsProton pump inhibitor4%Pantoprazole Sodium100%Part D≥63 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure
JACC: Cardiovascular Interventions
2023 - Severity of Ischemic Stroke After Left Atrial Appendage Closure vs Nonwarfarin Oral Anticoagulants
JACC. Clinical electrophysiology
2023 - Retrograde Coronary Venous Ethanol Infusion for Ablation of Refractory Left Ventricular Summit Arrhythmias
Cardiac Electrophysiology Clinics
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Bita Esmaeli, MD
Houston Methodist
Sherif Nagueh, MD
Houston Methodist
Neal Kleiman, MD
Houston Methodist
Miguel Quinones, MD
Houston Methodist
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”